7-Methylimidazo[1,2-a]pyridine-2-carboxylic acid

Catalog No.: 
ACSBCV831
CAS No.: 
80353-94-2
Molecular Formula: 
C9H8N2O2
Molecular Weight: 
176.18
7-Methylimidazo[1,2-a]pyridine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$64.00In stockIn stock
5g95%$260.00In stockIn stock
25g95%$1030.00In stockInquiry
100g95%$3362.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Methylimidazo[1,2-a]pyridine-2-carboxylic acid
IUPAC Name7-methylimidazo[1,2-a]pyridine-2-carboxylic acid
MDL No.MFCD03425067
Molecular FormulaC9H8N2O2
Molecular Weight176.18
SMILESO=C(C1=CN2C=CC(C)=CC2=N1)O
InChI KeyGWOWWQVYWZHBRI-UHFFFAOYSA-N
SynonymBionet2_001134 | 7-Methylimidazo[1,2-a]pyridine-2-carboxylic acid, AldrichCPR | AM20070241 | FT-0745651 | SCHEMBL1759007 | J-519317 | 7-methyl-2-imidazo[1,2-a]pyridinecarboxylic acid | F9995-2683 | MFCD13194051 | 7-methylimidazo[1,2-a]pyridine-2-carboxyli
CAS No.80353-94-2
PubChem CID1072555

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H317
Precautionary Statement(s)
P261-P280

Synthetic Route by SureRoute

1. ACSBCV831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFJHT528 route compound structure diagram
    ACFJHT52870705-33-8In Stock
  2. Then
  3. ACSBCV831 route product structure diagram
    ACSBCV83180353-94-2In Stock
Inquiry

2. ACSBCV831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSBCV831 route product structure diagram
    ACSBCV83180353-94-2In Stock
Inquiry

3. ACSBCV831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSBCV831 route product structure diagram
    ACSBCV83180353-94-2In Stock
Inquiry

Comments (0)